Appropriate Duration of Anti-Platelet and Thrombotic Strategy After 12 Months in Patients With Atrial Fibrillation Treated With Drug Eluting Stents
Condition: Atrial Fibrillation Interventions: Drug: Apixaban monotherapy; Drug: Dual therapy with apixaban and clopidogrel Sponsor: Yonsei University Not yet recruiting
Source: ClinicalTrials.gov - Category: Research Source Type: clinical trials